Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-012794
Filing Date
2025-05-13
Accepted
2025-05-13 17:05:10
Documents
1
Period of Report
2025-05-09

Document Format Files

Seq Description Document Type Size
1 form4-05132025_050505.html 4  
1 form4-05132025_050505.xml 4 3567
  Complete submission text file 0001415889-25-012794.txt   4975
Mailing Address 200 N SEPULVEDA BLVD PO BOX 956 MS ES/001/A102 EL SEGUNDO CA 90245
Business Address
AUSTIN ROXANNE S (Reporting) CIK: 0001061632 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35565 | Film No.: 25941213

Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Issuer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)